Christopher D'Angelo, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    research funding
    Date added:
    01/14/2024
    Date updated:
    01/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Fate Therapeutics
    Topic:
    research funding
    Date added:
    01/14/2024
    Date updated:
    01/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Beigene
    Topic:
    research funding
    Date added:
    01/14/2024
    Date updated:
    01/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Ono Pharma Inc
    Topic:
    research funding
    Date added:
    01/14/2024
    Date updated:
    01/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Ono Pharma
    Topic:
    advisory board meeting
    Date added:
    01/14/2024
    Date updated:
    01/14/2024
    Relationship end date:
    12/09/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    advisory board meeting
    Date added:
    01/14/2024
    Date updated:
    01/14/2024
    Relationship end date:
    12/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Seagen
    Topic:
    advisory board meeting
    Date added:
    01/14/2024
    Date updated:
    01/14/2024
    Relationship end date:
    08/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Abbvie
    Topic:
    consultant
    Date added:
    01/14/2024
    Date updated:
    01/14/2024
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Curis Inc
    Topic:
    research funding
    Date added:
    01/14/2024
    Date updated:
    01/14/2024
Return to 2024 Wisconsin Multiple Myeloma & Lymphoma Summit